The modest beat and flat revenue growth suggest limited upside catalyst. Watch for trends in ADV and clearing fees in Q3; the record Q1 was boosted by macro volatility, which may not repeat. The buyback provides a floor but doesn't drive growth.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 22 $249.24entry
- T+1 · 4mo ago +2.04%α +3.27% · $254.32
- T+5 · 4mo ago +6.50%α +8.90% · $265.44
- T+20 · 3mo ago +7.10%α +4.20% · $266.94
- T+60 · 5w ago +16.14%α +12.88% · $289.46
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CME Group reported Q2 2026 adjusted EPS of $2.99, beating consensus of $2.91 by 2.8%, and revenue of $1.71B, slightly above the $1.68B estimate. However, total revenue was essentially flat YoY (+0.8%), and core clearing and transaction fees declined 2.6% YoY. The company highlighted record market data revenue (+20% YoY to $238M) and continued share repurchases ($695M in Q2), but the lack of top-line growth and deceleration from a record Q1 suggest a neutral near-term outlook.
Key Financial Metrics
Key Facts
- Q2 2026 adjusted diluted EPS $2.99 vs consensus $2.91 (beat by 2.8%)
- Total revenue $1,706.2M vs $1,692.0M YoY (+0.8%)
- Clearing and transaction fees $1,352.5M, down 2.6% YoY from $1,388.0M
- Market data revenue record $238.1M, up 20% YoY
- Average daily volume (ADV) 29.8M contracts, third-highest quarterly ADV
- Average rate per contract $0.678, down from $0.690 YoY
- Repurchased $695M in common shares during Q2; paid $468M in dividends
- Cash $2.1B, debt $3.4B as of June 30, 2026
Financial Impact
EPS beat by ~$0.08, revenue beat by ~$26M; no guidance provided
Risk Factors
- Declining average rate per contract and clearing fee revenue trend
- Volume normalization after record Q1
- Execution risk in cloud transition and new product launches
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001156375-26-000042 |
| Document: cme-20260722.htm | 0001156375-26-000042 |
| Document: 0001156375-26-000042-index-headers.html | 0001156375-26-000042 |
| Document: 0001156375-26-000042-index.html | 0001156375-26-000042 |
| Document: 0001156375-26-000042.txt | 0001156375-26-000042 |
| 8-K Data (Synthetic) | 0001156375-26-000042 |
Track record
29 reports on CME
4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +17.81% at T+60 after the Mar 12, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $315.87 Now $319.37 +1.11% settles Feb 9
- Nov 9, 20267d ago 144 Neutral 1/10 Entry $304.52 Now $319.37 +4.88% settles Feb 5
- Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $308.27 Now $319.37 +3.60% settles Feb 2
- Nov 2, 202614d ago Insider Cluster Neutral 2/10 Entry $304.06 Now $319.37 +5.04% settles Feb 1
- Nov 2, 202614d ago 3 Neutral 2/10 Entry $304.06 Now $319.37 +5.04% settles Feb 1
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $304.06 Now $319.37 +5.04% settles Feb 1
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $306.24 Now $319.37 +4.29% settles Jan 29
- Oct 27, 202620d ago Insider Cluster Neutral 2/10 Entry $294.04 Now $319.37 +8.61% settles Jan 26
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $294.04 Now $319.37 +8.61% settles Jan 26
- Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $305.71 Now $319.37 +4.47% settles Jan 21
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers